The company repurchased and retired 4,313,000 shares in the open market for a total cost (excluding excise taxes) of $270 million for the three months ended March 31, 2025. This demonstrates a commitment to returning capital to shareholders.

In January 2025, the company's Board of Directors authorized a common stock dividend of $0.17 per share, payable on March 17, 2025. In April 2025, the company's Board of Directors authorized a common stock dividend of $0.17 per share, payable on June 16, 2025.

Recent funding and staff reductions, including at the EPA, the USDA, the FDA, and the HHS, could hinder the company's ability to receive timely regulatory approvals. This could impact the commercialization of products and the value of intellectual property.

Cost of goods sold totaled $2,342 million, down from $2,550 million in the first quarter of 2024. The improvement was driven by ongoing cost and productivity actions, Crop Protection raw material deflation, lower commodity prices, a reduction in net royalty expense and favorable currency effects.

Restructuring and asset related charges - net were $22 million, a decrease from $75 million in the first quarter of 2024. This indicates progress in optimizing operations and reducing costs.

In August 2022, Bayer filed breach of contract/declaratory judgment lawsuit in Delaware state court against Corteva relating to an agrobacterium cross-license agreement and E3® soybeans. Further information with respect to these proceedings is set forth under "Bayer Dispute" in Note 12 - Commitments and Contingent Liabilities, to the Consolidated Financial Statements.

In August 2022, Corteva filed a lawsuit against Bayer CropScience LLP and Monsanto Company (collectively "Bayer") in federal court in Delaware for alleged infringement of Corteva's patented AAD-1 herbicide resistance technology used in Enlist® corn.

On September 27, 2023, Corteva filed a lawsuit in Delaware federal court against Inari Agriculture, Inc. and Inari Agriculture N.V. (collectively “Inari”) asserting claims of Plant Variety Protection infringement, indirect patent infringement, breach of contract, and civil conversion.

An accrual was established for Corteva's estimated voluntary contribution to the solid waste and wastewater remedial action plans for the AltEn location. This indicates a commitment to addressing environmental concerns related to past operations.

EIDP's CEO and CFO concluded that disclosure controls and procedures were not effective at the reasonable assurance level, due to a material weakness in internal control over financial reporting related to the appropriate classification of cash flows related to intercompany transactions between EIDP and Corteva. This indicates a need for improved oversight and control processes.

EIDP has introduced enhancements that were previously disclosed in Item 9A of our Annual Report on Form 10-K for the year ended December 31, 2024 to the design of its disclosure controls and procedures as they relate to the presentation of intercompany activity between EIDP and Corteva within the EIDP Consolidated Statements of Cash Flows.